drugset / Trial / NCT02285699
The Gut Microbiota in Obsessive-Compulsive Disorder
NaSingle-groupOpen-labelOther
Summary
This study will examine the gut microbiota and serum inflammatory markers in patients with Obsessive-Compulsive Disorder vs. healthy controls. Phase II of the study will examine the gut microbiota and cytokine levels following 12-weeks of treatment with Selective Serotonin Reuptake Inhibitors (SSRIs).
Timeline
- Start
- 2014-11-01
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Citalopram | Small molecule | — | — |
| Subject | Escitalopram | Small molecule | — | — |
| Subject | Fluoxetine | Small molecule | — | — |
| Subject | Fluvoxamine | Unknown | — | — |
| Subject | Paroxetine | Small molecule | — | — |
| Subject | Sertraline | Small molecule | — | — |